(Q34144333)

31 July 2017

title

Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling (English)

1 reference

31 July 2017

8

Narod SA

1 reference

31 July 2017

Liede A

1

1 reference

31 July 2017

Metcalfe K

2

1 reference

31 July 2017

Hanna D

3

1 reference

31 July 2017

Hoodfar E

4

1 reference

31 July 2017

Snyder C

5

1 reference

31 July 2017

Durham C

6

1 reference

31 July 2017

Lynch HT

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

3 November 2000

1 reference

American Journal of Human Genetics

31 July 2017

published in

1 reference

31 July 2017

volume

67

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1494-1504

1 reference

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Cancer risks in BRCA2 mutation carriers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Men in breast cancer families: a preliminary qualitative study of awareness and experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

A descriptive study of BRCA1 testing and reactions to disclosure of test results

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Interest in genetic testing among first-degree relatives of breast cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Cancer Risk Assessment and Genetic Counseling in an Academic Medical Center: Consultands' Satisfaction, Knowledge, and Behavior in the First Year.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1287926

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

28 October 2018

1 reference

12 December 2020

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians

1 reference

12 December 2020

Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective

1 reference

12 December 2020

Genetic counseling for families with inherited susceptibility to breast and ovarian cancer

1 reference

12 December 2020

Informational needs of individuals and families with hereditary cancers

1 reference

12 December 2020

A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing

1 reference

12 December 2020

Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma

1 reference

12 December 2020

The influence of psychological distress on use of genetic testing for cancer risk

1 reference

12 December 2020

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing

1 reference

12 December 2020

Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer

1 reference

12 December 2020

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

12 December 2020

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

1 reference

12 December 2020

Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members

1 reference

12 December 2020

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study

1 reference

12 December 2020

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1086/316907

1 reference

31 July 2017

1 reference

31 July 2017

1 reference